390 filings
Page 4 of 20
6-K
GMAB
Genmab
5 Sep 23
Current report (foreign)
9:12am
6-K
GMAB
Genmab
16 Aug 23
Current report (foreign)
1:44pm
6-K
GMAB
Genmab
15 Aug 23
Current report (foreign)
3:06pm
6-K
GMAB
Genmab
3 Aug 23
Genmab Announces Financial Results for the First Half of 2023
11:16am
6-K
GMAB
Genmab
27 Jul 23
Genmab Updates 2023 Financial Guidance
6:15pm
6-K
GMAB
Genmab
21 Jul 23
Current report (foreign)
9:08am
6-K
GMAB
Genmab
20 Jul 23
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2023
9:00am
6-K
GMAB
Genmab
27 Jun 23
Current report (foreign)
6:54pm
6-K
GMAB
Genmab
21 Jun 23
Current report (foreign)
11:18am
6-K
GMAB
Genmab
20 Jun 23
Capital Increase in Genmab as a Result of Employee Warrant Exercise
3:58pm
6-K
GMAB
Genmab
20 Jun 23
Current report (foreign)
12:57pm
6-K
GMAB
Genmab
8 Jun 23
Current report (foreign)
5:27pm
6-K
GMAB
Genmab
1 Jun 23
Current report (foreign)
4:24pm
6-K
GMAB
Genmab
31 May 23
Current report (foreign)
9:44am
6-K
GMAB
Genmab
24 May 23
Current report (foreign)
10:46am
6-K
GMAB
Genmab
23 May 23
Capital Increase in Genmab as a Result of Employee Warrant Exercise
3:26pm
6-K
GMAB
Genmab
19 May 23
Current report (foreign)
12:48pm
6-K
GMAB
Genmab
10 May 23
Genmab Announces Financial Results for the First Quarter of 2023
11:23am
6-K
GMAB
Genmab
24 Apr 23
Genmab To File Appeal in Its Second Arbitration Under License Agreement with Janssen
8:58am
6-K
GMAB
Genmab
20 Apr 23
Genmab Announces Initial Resolution of Its Second Arbitration Under License Agreement with Janssen
8:18pm